ADVERTISEMENT

Retail

In Challenge To Age-Restricted Sales, CRN Argues Court ‘Diluted Constitutional Protections’

CRN’s attorneys ask Second Circuit for en banc review of a three-judge panel’s denial of its appeal of 2024 decision in district court rejecting motion for preliminary injunction against enforcement of New York state law age-restricting sales of weight loss and muscle building supplements.

Industry’s Battle Against Age-Restricting Supplement Sales Spreads To Michigan

Lawmakers in IL, MA and NJ as well as MI consider proposals as firms marketing weight loss and bodybuilding supplements in New York already are subject to first-ever state law limiting sales of products to consumers 18 and older.

Prebiotic Ingredient Firm Comet Forecasts Trail Of GLP-1 Popularity Driving Gut Health Concern

Canadian firm states in 2026 forecast that its research, including consumer surveys and sales data, shows a majority of consumers, 65%, are not only familiar with the benefits of prebiotics but also interested in the ingredients, 55%.

Appeals Court Clips CRN’s Constitutional Argument Against Age-Restricting Supplement Sales

Three-judge Second Circuit panel rejects CRN’s argument that New York General Business Law Section 391-oo, effective since April 2024 as first in US to prohibit sales of certain supplements to consumers under 18, violates First Amendment rights of supplement marketers.

HBW Insight US Executive News: AHPA, CRN Awards; Welch’s Brand Chief, Solarea CEO, More

Testing network Certified Group names CFO; Brooke Burke a Power Life ambassador; Solarea names CEO; Welch’s appoints first brand, innovation chief; Deshanie Rai recognized as CRN/Radicle Science Trailblazer; first McGuffin award goes to Native Botanicals president.

‘You Are Very Regulated’: Consumer Health And Beauty Industries’ Attention Needed In California

Regulations likely holding consumer product firms’ attention include the Plastic Pollution Prevention and Packaging Producer Responsibility Act, SB 54, scheduled to become effective by 2027. “Easily the most significant, extended producer responsibility law ever to pass in the world,” says lobbyist

‘Super Confused’ About Nutrition And Supplements, Do US Consumers Need Dieticians For Answers?

Studies and surveys “all point to one thing, that consumers don't understand nutrition,” says marketing consultant Stephen McCauley. Registered dieticians, including some with a nutrition specialty, are strong candidates to help health and wellness firms clear up the confusion.

CRN Stokes Freedom Of Speech Fire Challenging New York’s Age-Restricted Supplement Sales

Filing references Second Circuit ruling on New York attorney general’s appeal of lower court’s finding that state’s laws on unauthorized practice of law unfairly limited services by nonprofit providing free legal advice to residents facing debt-collection actions.

Nutrafol Pitches Growth With MLB As Spreading Baldness, Personalization Interest Drive Demand

Nutrafol competes for share in global hair growth in market of drug, supplement and other products estimated in one report at $7.7bn in 2023 and projected to reach nearly $11.6bn by 2030, or $25bn by 2034 according to a second report. Brand’s "Hats Off" campaign will include testimonials from baseba

PLT Health Wants Sports Nutrition Marketers To Know Consumers Like ‘Feeling Good’

Nutritional ingredient developer publishes results survey, with responses from 546 men and women in five countries, in a report looking at trends in cognitive and mood and with findings on consumers’ active nutrition goals, with a focus on the “concept of feeling good.”

US Tax Code Already Spells Using HSA/FSAs For Dietary Supplement Purchases, NPA Tells IRS

Internal Revenue Code should include within its definition of “medical care” spending the consumers' purchases of supplement products based on labeling of FDA-approved health and structure/function claims, NPA CEO Daniel Fabricant says.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.